CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K/A Event Shareholder vote results
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 5,813,954 shares at $3.75 ($21,802,328)
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 4 Open-market buy 10% owner bought 4,000,000 shares at $4.00 ($16,000,000)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Open-market buy Director bought 12,000 shares at $4.00 ($48,000)
- 4 Open-market buy Director bought 25,000 shares at $4.00 ($100,000)
- 4 Open-market buy EVP, CSO and CMO bought 4,500 shares at $4.00 ($18,000)
- 4 Open-market buy EVP, CFO bought 5,000 shares at $4.00 ($20,000)
- 4 Open-market buy President and CEO bought 30,000 shares at $4.00 ($120,000)
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
Page 26 of 50 · 1,000 filings